Brief: ORIC Pharmaceuticals Presents Promising Preclinical Data On Two Programs
18/04/2023 21:19
April 18 (Reuters) - Oric Pharmaceuticals Inc ORIC.O :
* ORIC PHARMACEUTICALS PRESENTS PROMISING PRECLINICAL DATA
ON TWO
PROGRAMS AT THE 2023 AMERICAN ASSOCIATION FOR CANCER RESEARCH
(AACR) ANNUAL MEETING
Source text for Eikon: ID:nGNX8KGzR8
Further company coverage: ORIC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ORIC Pharmaceuticals
See all newsBrief: Oric® Pharmaceuticals Announces Agreement With Cancer Research UK
ORIC Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: ORIC Pharmaceuticals Q1 Operating Expenses USD 39.619 Million
Brief: Oric Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ORIC Pharmaceuticals Q4 loss narrows